The Cancer Center Support Grant

As a dermatologist and dermatopathologist, Kenneth Tsai, M.D., Ph.D., has set his sights on preventing squamous cell carcinoma — the second most common form of skin cancer in the United States.

People with inherited conditions that raise their risk of developing certain cancers, such as colon cancer, deal with a lot of anxiety that comes from uncertainty about their health. Hopefully, the work of Eduardo Vilar-Sanchez will one day alleviate that risk.

Dallas’ Lyda Hill is determined to help solve “the mystery that is cancer.”

An old blood test now offers new hope and possibility.

In 1983, Robert Bast Jr., M.D., and his colleagues published a seminal paper in the New England Journal of Medicine detailing his discovery of the protein CA-125 and its value in helping to predict if ovarian cancer might recur.

Imagine if oncologists around the world had access to the expertise of MD Anderson’s physicians. The standard of cancer care would be greatly improved, and lives would be saved.

Historically, research and patient care have been kept separate or “siloed.” Guillermo Garcia-Manero wants to change that.

When Mary Cates was told she had cancer, she didn’t flinch . . . either time.

Cancer is a genomic disease, and Harshad Mahadeshwar’s job is to decode its weaknesses.

MD Anderson system is bolstered by Graduate Medical Education’s homegrown experts

A year in, this duo of deans is racking up the accomplishments

The first drug to improve the survival of people with end-stage melanoma works because of what it doesn’t do: attack tumors directly.

By boosting the number of T cells in his patients, Patrick Hwu is watching their immune systems defeat cancer.

Michael Gunter’s had time to think about melanoma.

Marit Peterson may be genetically predisposed to melanoma, but the disease was no match for her and her team.

When immune system T cells that can’t kill a patient’s cancer get a shot at those same tumor cells in the lab, it’s another story altogether.

Treatments relying on T cells, a key component of the body’s immune system, have had significant success, but a new experimental method customizes naturally produced cells to sharpen their attack on cancer.

Generally speaking, hypermutation and DNA damage in a cell are bad things. That is, unless you’re talking about an immune system B cell.

The Nocturnal Program ensures a seamless transition from day to night for patients

When Lakeisha Day sees a patient in the wee hours, she knows she needs to make the most of their limited time together.

Gloria Ayala walked into a hospital room and found a mother pacing while her daughter lay in bed. When Ayala was greeted with a big hug, she realized the experience was what being an MD Anderson volunteer was all about.

By exposing cancer cells, fluorescence makes surgeons’ jobs easier.

Treating cancer while preserving form and function.

Gift of gratitude boosts head and neck cancer research

Growing network of hospitals expands opportunities to end a global crisis